Pharmacoeconomics

Journal Title: Macedonian Journal of Medical Sciences (MJMS) - Year 2013, Vol 6, Issue 1

Abstract

Aim: The aim of this review was to provide an overview of the terminology, technology and methodology of pharmacoeconomic evaluations. The choice is made because there is small number of reviews on this subject in Macedonia, and also because of the subject actuality. Methods: There are four common types of methods of cost-outcomes economic evaluations: Cost-minimisation analysis, Cost-effectiveness analysis, Cost-utility analysis and Cost-benefit analysis. Results: There are 4 possible results arising in Cost-effectiveness analysis: the costs are lower and health benefits higher for one drug relative to another, the new drug is more expensive and less effective, the drug is more expensive and more effective and the drug is cheaper but less effective. Conclusion: Pharmacoeconomic methods are used to assist physicians, hospitals, insurers, patients and healthcare professionals in making proper decisions what drug therapies should be chosen. The goal is to find the most efficient and effective treatment for the lowest cost, optimising the patient outcomes and decreasing costs to society.

Authors and Affiliations

Marjan Dzeparoski| Bionika Pharmaceuticals, Skupi 15, 1000 Skopje, Republic of Macedonia

Keywords

Related Articles

Non-Foodborne Swine Zoonotic Diseases

The aim of this paper is to give an overview of novel swine non-foodborne zoonotic diseases that have been prominent in the last decade in swine industry. The number of swine present worldwide and the large percentage...

Isolation of Dental Pulp Stem Cells and their In Vitro Differentiation into Odontoblast-like Cells

Background: Recently, tooth tissue engineering has attracted more and more attention. Stem cell based tissue engineering is thought to be a promising way to replace the missing tooth. Mesenchymal stem cells (MSCs) are...

Contribution of Maternal Demographic and Medical Factors to the Risk of Prematurity in Qom Hospitals

Background. Prematurity remains the most significant cause of neonatal morbidity and mortality. Knowing which group of women is at risk for developing preterm labor will define a Target population for better prenatal c...

Maintenance Therapy with Rituximab in Adult Patients with Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is an autoimmune disease of unknown etiology, characterized by isolated thrombocytopenia and the absence of any underlying cause for thrombocytopenia. Corticosteroids are the standard firs...

Prevalence of Aspirin-Induced Asthma in Certain Group of Kosovo Population and its Presentation

Background. Aspirin-induced asthma (AIA) is characterized by onset of asthma attack 30 minutes to 3 hours after ingestion of aspirin or NSAIDs (Non steroid antiinflammatory drugs). The typical reaction may be accompanie...

Download PDF file
  • EP ID EP8917
  • DOI 10.3889/MJMS.1857-5773.2013.0282
  • Views 306
  • Downloads 15

How To Cite

Marjan Dzeparoski (2013). Pharmacoeconomics. Macedonian Journal of Medical Sciences (MJMS), 6(1), 102-105. https://europub.co.uk/articles/-A-8917